Advertisement

Picture Berlin Partner Voices Samedi AI for Medical Sector 650x100px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2145 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Azafaros B.V.. (5/13/25). "Press Release: Azafaros Secures € 132M in Oversubscribed Series B Financing to Advance Phase 3 Clinical Programs of Innovative Therapies in Lysosomal Storage Disorders". Leiden. 2025-05-13
Haya Therapeutics SA. (5/8/25). "Press Release: Haya Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases". Lausanne & San Diego, CA. 2025-05-08
Recursion Pharmaceuticals, Inc.. (5/6/25). "Press Release: Recursion to Participate in Upcoming Investor Conferences". Salt Lake City, UT. 2025-05-06
Recursion Pharmaceuticals, Inc.. (5/5/25). "Press Release: Recursion Reports First Quarter 2025 Financial Results and Provides Business Update". Salt Lake City, UT. 2025-05-05
Tozaro Ltd.. (5/1/25). "Press Release: Tozaro Appoints Dr. Jason Slingsby MBA as CEO to Lead Company Strategy in Cell and Gene Therapy Sector". Bedfordshire. 2025-05-01
Oryzon Genomics S.A.. (4/24/25). "Press Release: Oryzon Raises €30 Million in Capital Increase". Madrid & Cambridge, MA. 2025-04-24
Tessellate Bio B.V.. (4/23/25). "Press Release: Boehringer Ingelheim and Tessellate Bio Partner to Develop First-in-class Precision Treatments for People with Hard-to-treat Cancers". Ingelheim & Amsterdam. 2025-04-23
Alis Biosciences Ltd.. (4/18/25). "Press Release: Alis Biosciences Launches Fund to Free over USD$30 Billion of Capital Trapped in Listed Development-stage Life Sciences and Biotech Companies". London. 2025-04-18
ProBioGen AG. (4/17/25). "Press Release: GlymaxX-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy". Berlin. 2025-04-17
Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA. 2025-04-16
Sonrai Analytics Ltd.. (4/16/25). "Press Release: Sonrai and Paige Partner to Bring Advanced Machine Learning Capabilities to Biopharma". Belfast. 2025-04-16
AATec Medical GmbH. (4/15/25). "Press Release: AATec Medical Secures EUR 4 Million to Advance Lead Respiratory Drug Candidate to Clinical Development". Munich. 2025-04-15
Meribel Pharma Solutions. (4/15/25). "Press Release: Meribel Pharma Solutions Launches with Big Ambitions to Elevate Pharma Services to New Heights". 2025-04-15
Chromatin Bioscience Ltd.. (4/14/25). "Press Release: Chromatin Bioscience Signs Collaboration Agreement with Astellas". Edinburgh. 2025-04-14
Immunic, Inc.. (4/10/25). "Press Release: Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments". New York, NY. 2025-04-10
Cepheid. (4/9/25). "Press Release: Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-based Solutions". Oxford & Sunnyvale, CA. 2025-04-09
Sphere Bio Ltd.. (4/9/25). "Press Release: APAC Distribution Network Expanded to Strengthen Presence in Region". Cambridge. 2025-04-09
Angelini Ventures S.p.A.. (4/7/25). "Press Release: Angelini Ventures Appoints Seasoned Life Sciences Investor, Dr. Regina Hodits, as Managing Director". Rome. 2025-04-07
Dotmatics Ltd.. (4/2/25). "Press Release: Dotmatics Signs Definitive Agreement to Be Acquired by Siemens Advancing a New Era of AI-Driven Innovation in Life Sciences". Boston, MA. 2025-04-02
Coulter Partners. (4/1/25). "Press Release: Coulter Partners Announces Promotion of Penny Sadler to Managing Partner". 2025-04-01
Cosmo Pharmaceuticals N.V.. (4/1/25). "Press Release: Cosmo Appoints Federico Sommariva as Chief Legal Counsel". Dublin. 2025-04-01
Nuage Therapeutics S.L.. (4/1/25). "Press Release: Nuage Therapeutics Appoints Dr. Stuart Hughes as CEO and Vanessa Malier as Chair". Barcelona. 2025-04-01
Amboss SE. (3/25/25). "Press Release: Amboss Closes €240M Financing Round and Expands Its Position as the Leading Co-pilot for Physicians Worldwide". Berlin & New York, NY. 2025-03-25
AstraZeneca plc. (3/21/25). "Press Release: AstraZeneca to Invest $2.5 Billion in New Global Strategic R&D Centre, Biotech Agreements and Manufacturing in Beijing". 2025-03-21
British Business Bank plc. (3/21/25). "Press Release: British Business Bank Commits up to £30m to Thena Capital’s Inaugural UK MedTech Fund". 2025-03-21
Oxford BioTherapeutics Ltd.. (3/19/25). "Press Release: Oxford BioTherapeutics Enters into a Strategic Collaboration with Roche to Discover Novel Targets for Antibody-Based Therapeutics for the Treatment of Cancer". Oxford & San Jose, CA. 2025-03-19
Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners Exceeds Target with €165M Biotech Acceleration Fund, Europe’s Largest, with Strong Pharma Support". Paris. 2025-03-18
Sofinnova Partners. (3/18/25). "Press Release: Forth Tx Launches with Backing from Sofinnova Partners to Revolutionize Fibrosis Treatments". Edinburgh & Cambridge. 2025-03-18
[iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. 2025-03-18
Sofinnova Partners. (3/18/25). "Press Release: Sofinnova Partners and Gustave Roussy Launch First Biotech Company through Strategic Partnership". Paris. 2025-03-18
AstraZeneca plc. (3/17/25). "Press Release: AstraZeneca Enters License Agreement with Alteogen for Subcutaneous Formulations of Multiple Oncology Assets". 2025-03-17
EsoBiotec SA. (3/17/25). "Press Release: EsoBiotec to Be Acquired by AstraZeneca to Advance Cell Therapy Ambition". Mont-Saint-Guibert. 2025-03-17
Haya Therapeutics SA. (3/13/25). "Press Release: Haya Therapeutics Appoints Former Exscientia Executive Dr. Richard Law as Chief Business Officer". Lausanne & San Diego, CA. 2025-03-13
Centogene N.V.. (3/12/25). "Press Release: Centogene Closes Strategic Transaction with Private Equity Group Charme Capital Partners". Cambridge, MA, Rostock & Berlin. 2025-03-12
Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth. 2025-03-10
T-Therapeutics Ltd.. (3/10/25). "Press Release: T-Therapeutics Appoints Theodora Harold as Chief Executive Officer, Reflecting Company’s Ambitious Growth Plans and Progression into Therapeutic Development". Cambridge. 2025-03-10
Jazz Pharmaceuticals plc. (3/5/25). "Press Release: Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio". Dublin & Durham, NC. 2025-03-05
Xund Solutions GmbH. (3/5/25). "Press Release: Xund Secures Pre-Series A. 6 Million Euros to Strengthen European Leadership in AI-powered Healthcare". 2025-03-05
Trimtech Therapeutics Ltd.. (3/5/25). "Press Release: Trimtech Therapeutics Raises $31M Seed Funding to Advance Targeted Protein Degradation Pipeline for Treatment of Neurodegenerative Diseases". Cambridge. 2025-03-05
Epoch Biodesign Ldt.. (3/5/25). "Press Release: Epoch Biodesign Raises $18.3M to Turn the Plastic Crisis Into a Circular Revolution". London. 2025-03-05
Sofinnova Partners. (3/4/25). "Press Release: Sofinnova Partners Raises €1.2 Billion to Fuel the Next Wave of Life Sciences Innovation". Paris. 2025-03-04
Thermo Fisher Scientific Inc.. (2/25/25). "Press Release: Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business". Waltham, MA. 2025-02-25
Sphere Bio Ltd.. (2/25/25). "Press Release: Sphere Fluidics Rebrands to Sphere Bio". Cambridge. 2025-02-25
Nuclera Ltd.. (2/24/25). "Press Release: Nuclera Appoints Seth Benson as Chief Financial Officer". Cambridge. 2025-02-24
Chromatin Bioscience Ltd.. (2/20/25). "Press Release: Chromatin Bioscience Joins JLABS EMEA". Edinburgh. 2025-02-20
Anbio Biotechnology. (2/20/25). "Press Release: Anbio Biotechnology Announces Closing of Initial Public Offering". Frankfurt a. M.. 2025-02-20
FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA. 2025-02-20
Boehringer Ingelheim. (2/20/25). "Press Release: Boehringer Ingelheim and Partners Start Clinical Development of a First-in-Class, Inhaled Gene Therapy for People with Cystic Fibrosis". Ingelheim. 2025-02-20
Nuclera Ltd.. (2/18/25). "Press Release: Nuclera Appoints William J. Kullback as Non-Executive Director". Cambridge. 2025-02-18
Isopmorphic Labs Ltd.. (2/18/25). "Press Release: Isomorphic Labs Announces Novartis Collaboration Expansion". London. 2025-02-18
Anbio Biotechnology. (2/18/25). "Press Release: Anbio Biotechnology Announces Pricing of Initial Public Offering". Frankfurt a. M.. 2025-02-18
Latent Labs Ltd.. (2/13/25). "Press Release: Latent Labs Secures $50M in Funding to Realize the Potential of AI-powered, Programmable Biology". London & San Francisco, CA. 2025-02-13
Qureight Ltd.. (2/5/25). "Press Release: Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis". 2025-02-05
High-Tech Gründerfonds Management GmbH. (2/4/25). "Press Release: Akribion Therapeutics Exits from Stealth with €8m Seed Financing to Pioneer RNA-guided, Programmable cell depletion". 2025-02-04
Coulter Partners. (2/4/25). "Press Release: Coulter Partners Places Chief Business Officer at Our Future Health". 2025-02-04
Isopmorphic Labs Ltd.. (3/31/25). "Press Release: Isomorphic Labs Announces $600 Million Funding to Further Develop Its Next-generation AI Drug Design Engine and Advance Therapeutic Programs into the Clinic". London. 2025-01-31
Rentschler Biopharma SE. (1/30/25). "Press Release: Rentschler Biopharma Announces Strategic Realignment of Its Global Business Operations". Laupheim. 2025-01-30
Quibim S.L.. (1/28/25). "Press Release: Quibim Announces $50 Million in Series A Financing, Led by Asabys and Buenavista, to Revolutionize Precision Medicine with AI-Powered Imaging Biomarkers". Valencia & New York, NY. 2025-01-28
Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. 2025-01-27
Coulter Partners. (1/23/25). "Press Release: Coulter Partners Secures CEO Placement for NeoPhore". 2025-01-23
Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. 2025-01-21
Cormica Ltd.. (1/20/25). "Press Release: Cormica Expands European Operations with Acquisition of Zwisler Laboratorium GmbH". 2025-01-20
Chromatin Bioscience Ltd.. (1/20/25). "Press Release (News): Chromatin Bioscience Signs a Research Collaboration with Johnson & Johnson". 2025-01-20
Chromatin Bioscience Ltd.. (1/17/25). "Press Release: Chromatin Bioscience’s Synthetic Promoter Supports EsoBiotec’s ESO-T01 CAR-T Therapy as It Enters the Clinic". Edinburgh. 2025-01-17
Owlstone Medical Ltd.. (1/15/25). "Press Release: Owlstone Medical Announces $27 Million USD First Close in Series E Financing Round". Cambridge. 2025-01-15
Bioptimus SAS. (1/14/25). "Press Release: Bioptimus Hits $76M Funding Milestone and Prepares to Launch Groundbreaking Foundation Model for Biology". 2025-01-14
GSK plc. (1/13/25). "Press Release: GSK Enters Agreement to Acquire IDRx, Inc.". London. 2025-01-13
Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. 2025-01-10
Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. 2025-01-09
Oribiotech Ltd.. (1/9/25). "Press Release: Ori Biotech Expands Team to Advance IRO Commercialization and Industry Partnerships". London. 2025-01-09
EsoBiotec SA. (1/8/24). "Press Release: EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. 2025-01-08
Medix Biochemica Oy. (1/8/25). "Press Release: Medix Biochemica Welcomes Stefan Schorling to Its Leadership Team". 2025-01-08
Oribiotech Ltd.. (1/7/25). "Press Release: Ori Biotech Announces First Customer Deliveries of IRO to Leading CDMOs and Commercial CGT Manufacturers". London. 2025-01-07
Qiagen N.V.. (1/7/25). "Press Release: Qiagen Supports UK Initiative to Sequence Genomes of 100,000 Newborns With Expert-Curated Genomic Content". Redwood City, CA & Venlo. 2025-01-07
Ottimo Pharma Ltd.. (12/19/24). "Press Release: Ottimo Pharma Raises over $140 Million in Series A Financing". London & Boston, MA. 2024-12-19
NeoPhore Ltd.. (12/16/24). "Press Release: NeoPhore Appoints Michael Shih as Chief Executive Officer". London. 2024-12-16
2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". 2024-12-16
Andera Partners. (12/12/24). "Press Release: New York Life Investments and Its European Affiliate, Candriam, Announce Strategic Partnership with Andera Partners". New York, NY, Paris & Brussels. 2024-12-12
EsoBiotec SA. (12/11/24). "Press Release: EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma". Mont-Saint-Guibert. 2024-12-11
BenevolentAI Ltd.. (12/11/24). "Press Release: BenevolentAI Unveils Major Strategic Overhaul with Return to Original Mission". London. 2024-12-11
Siemens Healthineers AG. (12/10/24). "Press Release: Siemens Healthineers Acquires Advanced Accelerator Applications Molecular Imaging". 2024-12-10
Selvita S.A.. (12/10/24). "Press Release: Selvita Strengthens Management Structure in Sales and Drug Development Segment". Kraków. 2024-12-10
Relation Therapeutics Ltd.. (12/10/24). "Press Release: Relation Announces Two Strategic Collaborations with GSK to Advance Therapeutics for Fibrotic Diseases and Osteoarthritis". London. 2024-12-10
Oribiotech Ltd.. (12/10/24). "Press Release: Ori Biotech and Fresenius Kabi Collaborate to Advance Modular, Scalable Manufacturing of Cell and Gene Therapies". London & Bad Homburg. 2024-12-10
Dotmatics LLC. (12/10/24). "Press Release: Dotmatics and Databricks Partner to Advance Scientific Intelligence in Life Sciences". Boston, MA. 2024-12-10
Aqemia SAS. (12/10/24). "Press Release: Aqemia Hits $100 Million Funding Milestone, Paving Way to Clinical Trials and Global Expansion Starting with London, UK". Paris & London. 2024-12-10
Newcells Biotech Ltd.. (12/5/24). "Press Release: Newcells Biotech Raises Additional Funding from Investors". Newcastle. 2024-12-05
ViveBiotech S.L.. (12/4/24). "Press Release: ViveBiotech Secures Growth Investment from Ampersand Capital Partners to Expand Lentiviral Vector Development and Manufacturing Capabilities". 2024-12-04
Abselion (HexagonFab Ltd.). (12/4/24). "Press Release: Abselion Raises £6.6 Million Led by M Ventures to Bring Disruptive At-line Protein Analyser, Amperia, to Market". Cambridge. 2024-12-04
Orbit Discovery Ltd.. (12/3/24). "Press Release: Orbit Discovery and Evergreen Theragnostics Expand Research Collaboration to Advance Targeted Therapeutics Development". Oxford & Springfield, NJ. 2024-12-03
Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. 2024-11-26
Metrion Biosciences Ltd.. (11/25/24). "Press Release: Metrion Biosciences Appoints Lee Patterson as CEO". Cambridge. 2024-11-25
Enveda. (11/21/24). "Press Release: Enveda Closes $130M Series C Funding to Deliver Multiple Clinical Readouts from a Pipeline of 10 Development Candidates". Boulder, CO. 2024-11-21
Glox Therapeutics Ltd.. (11/20/24). "Press Release: Glox Therapeutics Awarded £1M PACE Grant to Accelerate Development of Precision Antibiotics Against Antimicrobial-resistant Pathogens". Glasgow. 2024-11-20
Tagomics Ltd.. (11/20/24). "Press Release: Tagomics Announces a Multiomic Profiling Co-Marketing Agreement with Agilent". Cambridge. 2024-11-20
Revvity, Inc.. (11/20/24). "Press Release: Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK". Waltham, MA. 2024-11-20
CRISPR Therapeutics AG. (11/14/24). "Press Release: CRISPR Therapeutics to Present at the Jefferies London Healthcare Conference". Zug & Boston, MA. 2024-11-14
Centogene N.V.. (11/13/24). "Press Release: Centogene Signs Strategic Transaction with Private Equity Group Charme Capital Partners [not for release, publication or distribution, where unlawful]". Cambridge, MA & Rostock. 2024-11-13
[iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. 2024-11-13
Tessellate Bio B.V.. (11/4/24). "Press Release: Tessellate Bio Announces Appointment of Lara Boyd as Chief Business Officer". Amsterdam & Stevenage. 2024-11-04
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22  next pagenext page



Advertisement

Picture biomindz Brand LSG Mainz Place to Biotech 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner BIO 2025 International Convention Boston 650x300px

» top